Brief: Pixium Vision Announces Regulatory Approval Of Remote Rehabilitation System For Patients In Clinical Trials
03/08/2022 06:04
Aug 3 (Reuters) - Pixium Vision SA ALPIX.PA :
* PIXIUM VISION ANNOUNCES REGULATORY APPROVAL OF REMOTE
REHABILITATION SYSTEM FOR PATIENTS IN CLINICAL TRIALS
* REMOTE REHABILITATION APPROVED IN FRANCE, GERMANY, ITALY,
SPAIN
AND NETHERLANDS
* FIRST FEATURE OF NEW REMOTE PATIENT ENGAGEMENT PLATFORM
ALLOWS
COMPLETION OF MOST OF POST-IMPLANTATION TRAINING AT HOME
* PRIMAVERA PIVOTAL TRIAL OF PRIMA SYSTEM ON TRACK TO
READ-OUT
AROUND END-2023
* OPENING OF ADDITIONAL CLINICAL SITES IS PLANNED IN SPAIN,
AND
ITALY DURING 2022
* EXPECTS TO COMPLETE RECRUITMENT BY END OF 2022, LEADING TO
A
READ-OUT OF PRIMAVERA STUDY AROUND END OF 2023 AND A REGULATORY
SUBMISSION IN EUROPE IN H1 2024
Source text for Eikon: urn:newsml:reuters.com:*:nGNX3MqQRT
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow